ORL-HNSUK ENT Reference
Sign inJoin free

Menu

HomeQuestion bankVivasFRCS curriculumISCP PortfolioENT AI AssistantCalculatorsSearchBuild LogAboutHelp and FAQContact
Sign in
HomeQbankVivas

Menu

HomeQuestion bankVivasFRCS curriculumISCP PortfolioENT AI AssistantCalculatorsSearchBuild LogAboutHelp and FAQContact
Sign in
·
  • Allergic Rhinitis2
  • Chronic Rhinosinusitis8
  • Acoustic Neuroma (Vestibular Schwannoma)18
  • Acute Otitis Media35
  • Anatomy and Physiology of Hearing43
  • Assessment of Balance10
  • Audiology and Hearing Investigations11
  • Auditory Neuropathy Spectrum Disorder and Auditory Processing Disorder42
  • Autoimmune Inner Ear Disease (AIED)4
  • Benign Paroxysmal Positional Vertigo (BPPV)8
  • Bone-Anchored Hearing Aids (BAHA)8
  • Cholesteatoma12
  • Cochlear Implantation in Children11
  • Cochlear implantation12
  • Eustachian Tube Dysfunction (ETD)4
  • Hearing Aids and Auditory Rehabilitation8
  • Mastoiditis and Complications of Otitis Media4
  • Middle Ear Implants
  • Ménière's Disease10
  • Necrotising Otitis Externa3
  • Non-Organic Hearing Loss1
  • Ossicular Chain Pathology and Reconstruction
  • Otitis Externa1
  • Otitis Media with Effusion (Glue Ear)10
  • Otosclerosis13
  • Sudden Sensorineural Hearing Loss (SSNHL)12
  • Temporal Bone Fractures
  • Tinnitus and Hyperacusis1
  • Tympanoplasty and Mastoidectomy
  • Aetiology of Head and Neck Cancer27
  • Cervical Lymphadenopathy1
  • Adenoidal Hypertrophy and Adenoidectomy24
  • Age-Appropriate Paediatric Hearing Assessment16
  • Cleft Palate (ENT Considerations)8
  • Neonatal and Infant Airway Disorders
  • Paediatric Tracheostomy and Airway Management8
  • Tonsillitis and Tonsillectomy
Notes
HomeNotesAllergic Rhinitis

Rhinology

Allergic Rhinitis

Updated 11 September 2026

Summary

  • Allergic rhinitis is diagnosed from compatible symptoms and exposure history. A positive skin-prick or specific IgE test shows sensitisation, which is clinically relevant only when it matches the history.

  • Treatment is stepped to symptom burden: antihistamine for intermittent itch and sneeze-predominant symptoms, regular intranasal corticosteroid for troublesome obstruction or moderate-to-severe disease, and a fixed intranasal antihistamine/corticosteroid combination when monotherapy is insufficient. BSACI rhinitis 2017 ARIA-EAACI2024–2025

  • Before escalating, assess coexisting asthma, spray technique and adherence. Allergen immunotherapy requires clinically relevant sensitisation, controlled asthma and product-specific eligibility and safety assessment. Acarizax UK SmPC

This is a preview

The full published note continues beyond this preview. Create a free account to read it during your included 7 days of Plus. No card required; your account stays free afterwards.

Create a free account